These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6075134)

  • 1. [Cutaneous reactions to tuberculin in cancer patients. Prognostic value].
    Israël L; Mawas C; Bouvrain A; Sors MC
    Bull Mem Soc Med Hop Paris; 1967 Mar; 118(5):469-76. PubMed ID: 6075134
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of clinical significance of tuberculin sensitization in patients with lung cancer].
    Knoring BE; Ariél' BM
    Probl Tuberk; 1996; (2):26-30. PubMed ID: 8657690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of antimitotic chemotherapy of inoperable bronchopulmonary cancer on immune processes (tuberculin allergy, immune globulins)].
    Migueres J; Jover A; Levy A
    Poumon Coeur; 1968; 24(3):351-4. PubMed ID: 4177880
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-mediated immunity in lung cancer patients: data, problems, and propositions.
    Israel L
    Cancer Chemother Rep 3; 1973 Mar; 4(2):279-81. PubMed ID: 4729330
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cellular immunity response as a prognostic factor in radiochemotherapy of inoperable lung cancer].
    Pivniuk VM; Kas'ianenko IV; Evceb'eva AI; Rafail'skaia IaB
    Vopr Onkol; 1982; 28(12):51-5. PubMed ID: 6184885
    [No Abstract]   [Full Text] [Related]  

  • 6. [Delayed hypersensitivity response of the skin to 2,4-dinitrochlorobenzene and old tuberculin in patients with lung cancer].
    Fan XJ
    Zhonghua Zhong Liu Za Zhi; 1983 Sep; 5(5):333-6. PubMed ID: 6653356
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnostic value of the tuberculin skin test as a parameter of cellular immunocompetence in cancer patients].
    Sone S; Ogushi F; Tsubura H; Fukuoka M
    Kekkaku; 1983 Oct; 58(10):559-62. PubMed ID: 6319794
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the tuberculin susceptibility of lung cancer patients (author's transl)].
    Jensen I
    Offentl Gesundheitswes; 1980 Jun; 42(6):311-3. PubMed ID: 6448374
    [No Abstract]   [Full Text] [Related]  

  • 9. [Corynebacterium parvum in advanced cancers. 1st evaluation of the therapeutic activity of this immunostimulin].
    Israël L; Halpern B
    Nouv Presse Med; 1972 Jan; 1(1):19-23. PubMed ID: 4110695
    [No Abstract]   [Full Text] [Related]  

  • 10. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03.
    Teramukai S; Kitano T; Kishida Y; Kawahara M; Kubota K; Komuta K; Minato K; Mio T; Fujita Y; Yonei T; Nakano K; Tsuboi M; Shibata K; Furuse K; Fukushima M
    Eur J Cancer; 2009 Jul; 45(11):1950-8. PubMed ID: 19231158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II evaluation of AMSA in patients with metastatic lung cancer.
    Nichols WC; Eagan RT; Frytak S; Ingle JN; Creagan ET; Kvols LK
    Cancer Treat Rep; 1980; 64(12):1383-5. PubMed ID: 6894104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of autoantibodies against p53 in Taiwanese lung cancer patients undergoing chemotherapy.
    Lee YL; Shih CM; Chiou HL; Shiau MY; Chang GC; Chang YH
    Clin Chim Acta; 2004 Nov; 349(1-2):87-96. PubMed ID: 15469860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The tuberculin test in cancer patients].
    Yarom J; Robinson E
    Harefuah; 1972 Dec; 83(12):542-3. PubMed ID: 4659021
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of the changes in several immunologic and metabolic parameters in bronchopulmonary cancer].
    Păunescu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987; 36(3):201-8. PubMed ID: 2831612
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy effectiveness in lung cancer].
    Korman DB; Mikaélian SG
    Sov Med; 1980; (1):28-33. PubMed ID: 7367974
    [No Abstract]   [Full Text] [Related]  

  • 16. [Non-surgical treatment of lung cancer].
    Lakartidningen; 1980 Sep; 77(39):3369-77. PubMed ID: 7453338
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiochemotherapy in lung cancer: from reality to reality.
    Jeremic B
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1349-51. PubMed ID: 19827994
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy.
    Sève P; Isaac S; Trédan O; Souquet PJ; Pachéco Y; Pérol M; Lafanéchère L; Penet A; Peiller EL; Dumontet C
    Clin Cancer Res; 2005 Aug; 11(15):5481-6. PubMed ID: 16061864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tuberculin intradermoreaction as a survival test in patients with inoperable pulmonary carcinoma].
    Giorgis GE; Galietti F; Barberis S; Ardizzi A; Ferrua M
    Arch Sci Med (Torino); 1981; 138(4):493-6. PubMed ID: 6280641
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research on the prognostic value of immunodeficiency in Hodgkin's disease].
    Szász B; Dudea C; Róna L; Kifor I; Borsai G; Zegrean G; Rad L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(6):511-20. PubMed ID: 6113670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.